Nilai Dipunlarasaken Utang lan Kas: salariuspharma.com (SLRX)
The investment potential of Salarius Pharmaceuticals (SLRX) is speculative due to the early stages of therapy development. The asset's price trajectory reflects an Enterprise Value of 0.55. The business leverages AI and robotics to accelerate drug synthesis, eliminating laboratory routine. Patents and massive clinical trial expenditures create a high barrier to entry in pediatric oncology.
Ringkesan rincian data analitis Salarius Pharmaceuticals (SLRX)
- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
- informasi kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Salarius Pharmaceuticals|SLRX - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal salariuspharma.com|SLRX - Gunggung utang perusahaan|Utang marang nilai buku Salarius Pharmaceuticals|SLRX - Utang jangka dawa perusahaan|Utang jangka cendhak Salarius Pharmaceuticals
Ringkesan analitik perusahaan:SLRX - Salarius Pharmaceuticals Inc
This metric aggregates market capitalization and net debt, determining the actual cost of a full business buyout while accounting for liquidity and liabilities. Given the absence of revenue and the dependence of Salarius Pharmaceuticals (SLRX) on clinical trial outcomes, the enterprise value including net debt serves as an indicator of capital resilience in the face of potential drug development failures.
Karo sapa Salarius Pharmaceuticals saingan
BeiGene Ltd. - Nilai Total Perusahaan|HALO - Nilai Total Perusahaan|Nilai Dipunlarasaken Utang lan Kas RVMD (Revolution Medicines Corp)|AAPG (Ascentage Pharma Group) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Bisnis CGON|URGN (UroGen Pharma) - Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Bicara Therapeutics Inc (BCAX)|Nilai Perusahaan PSNL|Nilai Perusahaan Erasca Oncology (ERAS)|Nilai Total Perusahaan Delcath Systems, Inc. DCTH|YMAB: Nilai Bisnis|Aura Biosciences - Nilai Perusahaan|Candel Therapeutics (CADL) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|ARAY: Nilai Perusahaan|Total Nilai Perusahaan SELLAS Life Sciences Group (SLS)|Nilai Total Perusahaan Actuate Therapeutics, Inc.|CTOR: Nilai Dipunlarasaken Utang lan Kas|Rega Nyata Tumbas Perusahaan Kanthi Wutuh HURA (TuHURA Biosciences, Inc.)|TARA (Protara Therapeutics Inc) - Nilai Dipunlarasaken Utang lan Kas|Nilai Perusahaan FATE (Fate Therapeutics Corp)|WHWK - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|TCRX: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|CSBR - Nilai Perusahaan|xbiotech.com (XBIT) - Nilai Total Perusahaan|CEL-SCI - Nilai Dipunlarasaken Utang lan Kas|OSTX (OS Therapies Inc) - Nilai Perusahaan|Total Nilai Perusahaan radiopharmtheranostics.com RADX|Nilai Total Perusahaan Artiva Biotherapeutics, Inc. (ARTV)|Rega Tumbas Perusahaan adlainortye.com|Nilai Perusahaan VERU (Veru)|Nilai Perusahaan Tempest Therapeutics Inc TPST|XLO - Nilai Total Perusahaan|RENB: Nilai Total Perusahaan|MURA: Nilai Perusahaan|Kairos Pharma (KAPA) - Nilai Perusahaan|Nilai Total Perusahaan OnKure Therapeutics, Inc.|GDTC: Nilai Dipunlarasaken Utang lan Kas|Nilai Perusahaan CRIS|Rega Tumbas Perusahaan apollomicsinc.com|Tharimmune, Inc. - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Perusahaan Advanced Biomed Inc. ADVB|GNPX - Nilai Total Perusahaan|Rega Tumbas Perusahaan Calidi Biotherapeutics CLDI|SBFM (Sunshine Biopharma, Inc.) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Xenetic Biosciences, Inc. - Nilai Dipunlarasaken Utang lan Kas|Nilai Total Perusahaan Purple Biotech|AON - Nilai Wutuh Bisnis|Nilai Perusahaan BGNE|CKPT (Checkpoint Therapeutics Inc.) - Nilai Dipunlarasaken Utang lan Kas|Nilai Perusahaan ELEV (Elevation Oncology)|Nilai Perusahaan iCAD Inc. ICAD|IKNA - Nilai Total Perusahaan|Nilai Dipunlarasaken Utang lan Kas NTBL (notablelabs.com)|viracta.com (VIRX) - Nilai Total Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh MorphoSys Inc|NAYA (NAYA Bio) - Nilai Perusahaan|Nilai Perusahaan Ascentage